Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8,033.00 JPY | +1.35% |
|
+0.32% | -6.59% |
Feb. 07 | Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ended December 2024 | CI |
Jan. 13 | Otsuka Says US FDA to Hold Advisory Meeting for PTSD Treatment Combo | MT |
P/E ratio (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Yield (Y) | Capi.($) | ||
---|---|---|---|---|---|---|---|---|---|
16.8x | 1.68x | 0.15x | 1.68x | 8.03x | 11.97x | 1.52% | 28.45B | ||
35.49x | 5.72x | 1.59x | 7.45x | 25.98x | 31.31x | 0.82% | 47.52B | ||
31.32x | 2.35x | 0.04x | 2.4x | 12.32x | 14.14x | 1.27% | 21.47B | ||
23.73x | 3.84x | 1.16x | 3.98x | 15.41x | 18.2x | 0.77% | 13.47B | ||
20.83x | 4.05x | 0.97x | 4.12x | 13.98x | 16x | 0.6% | 11.1B | ||
15.01x | 2.31x | 1.79x | 2.39x | 8.78x | 11.01x | 4.43% | 5.23B | ||
8.55x | 1.56x | 0.18x | 2.13x | 5.81x | 7x | 4.71% | 5.04B | ||
29.53x | 4.71x | -0.15x | 2.95x | 15.87x | 19.57x | 0.19% | 4.88B | ||
11.48x | 0.88x | -0.23x | 1.62x | 7.1x | 8.98x | 5.22% | 4.74B | ||
53.18x | 3.95x | 6.38x | 8.13x | 31.37x | 47.01x | 0.33% | 4.57B | ||
12.7x | 0.84x | 0.37x | 2.07x | 7.92x | 9.51x | 2.2% | 4.07B | ||
35.17x | 7.71x | 2.5x | - | - | - | 0.73% | 3.71B | ||
29.12x | 7.14x | 0.92x | 8.26x | 24.79x | 28.46x | 2.08% | 3B | ||
22.5x | 3.09x | 13.65x | 2.39x | 11.22x | 16.17x | 0.19% | 2.3B | ||
17.57x | 2.12x | 0.48x | 2.07x | 10.22x | 13.25x | 2.2% | 2.2B | ||
Average | 24.20x | 3.46x | 1.99x | 3.69x | 14.20x | 18.04x | percentage-no-prefix | 10.78B | |
Weighted average by Cap. | 26.65x | 3.69x | 1.18x | 4.29x | 16.29x | 20.19x | percentage-no-prefix |
- Stock Market
- Equities
- 4578 Stock
- Sector Otsuka Holdings Co., Ltd.
- Sector valuations